Brian Kim, MD
Clinical Cardiac Electrophysiology · Kearney, NENPI 1609849876
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $322,936 of the $455,179 with a category attached, or 70.9%. 32 manufacturers reported payments, led by Acutus Medical, Inc. at 56.9% of the total. Reporting peaked in 2023 at $148,630 and has fallen 95.4% since, to $6,776 in 2025. Among clinical cardiac electrophysiology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 975 payments — averaging $466.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acutus Medical, Inc.$259K
- Abbott$93K
- Medtronic$51K
- Biosense Webster, Inc.$26K
- Biotronik Inc.$19K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
- plus $5K from 26 others
Across 43 payments — averaging $3245.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$136K
- Boston Scientific$3K
What the payments were for
- Consulting fees$322,93671%
- Speaking & faculty fees$38,5508%
- Travel & lodging$46,94810%
- Food & beverage$46,72310%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acutus Medical, Inc. | 69 | $259,040 |
| Abbott | 237 | $92,535 |
| Medtronic(2 entities) | 267 | $50,922 |
| Biosense Webster, Inc. | 115 | $26,285 |
| Biotronik Inc. | 86 | $19,314 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $1,731 |
| Medical Device Business Services, Inc. | 4 | $1,160 |
| Atricure, Inc. | 9 | $853 |
| Novartis | 76 | $612 |
| Sanofi-aventis U.S. LLC | 26 | $491 |
| Boston Scientific | 10 | $475 |
| Johnson & Johnson | 17 | $311 |
| Impulse Dynamics (USA) Inc. | 3 | $286 |
| E.r. Squibb & Sons, L.L.C. | 9 | $246 |
| Amgen | 8 | $186 |
| Pfizer | 6 | $119 |
| W. L. Gore & Associates, Inc. | 1 | $101 |
| Heartflow, Inc. | 4 | $73 |
| Kestra Medical Technology Services, Inc. | 2 | $50 |
| Cvrx, Inc. | 1 | $48 |
| Cardiovascular Systems Inc. | 2 | $42 |
| Bardy Diagnostics, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $35 |
| Baxter Healthcare | 1 | $33 |
| Cardiofocus, Inc. | 1 | $32 |
| Cardiva Medical, Inc. | 2 | $28 |
| Irhythm Technologies, Inc. | 1 | $27 |
| Biotissue Holdings Inc. | 1 | $25 |
| Biotronik NRO, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Convatec Inc. | 1 | $19 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AcQGuide$48,750
- Micra$34,787
- AVEIR$17,123
- ACCENT$14,400
- GALLANT$13,200
- Carto 3$12,074
- ALLURE QUADRA$11,025
- Carto 3 System$9,716
- Carto Smarttouch$9,365
- Carto CFAE$9,365
- CartoSound$9,365
- ALLURE$6,800
- Device$4,750
- BioMonitor$4,728
- Allure CRT Pacemaker$4,600
- Solia$4,314
- Nanostim Leadleas Pacemaker$4,096
- Allure Quadra RF CRT Pacemaker$3,876
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$3,280
- Acticor 7 VR-T DX$3,240
How this compares
$455,179 in reported general payments places this provider in the 95th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
See all clinical cardiac electrophysiology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 181 | $163,796 |
| XareltoRivaroxaban | 52 | $65,698 |
| Flecainide Acetate | 44 | $1,176 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 27 | $914 |
| Metoprolol Succinate | 53 | $810 |
| SotalolSotalol Hcl | 24 | $552 |
| Metoprolol Tartrate | 72 | $405 |
| Atenolol | 33 | $287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $119 | $163,796181 claims |
| Johnson & JohnsonXarelto | $311 | $65,69852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
Other clinical cardiac electrophysiology in Kearney
- Hussam AbuissaOmaha$162K
- Jeffrey MahoneyOmaha$118K
- Shane TsaiOmaha$68K
- Jason PayneOmaha$59K
- Grant WallaceLincoln$59K
- Peter GallagherLincoln$48K
- Stephen AckermanLincoln$45K
- Matthew SorensenOmaha$30K
- David SternsOmaha$28K
- Matthew KapalisOmaha$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.